Logo image of NXRT

NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NXRT - US65341D1028 - REIT

31.77 USD
-0.23 (-0.72%)
Last: 11/26/2025, 8:04:00 PM
31.77 USD
0 (0%)
After Hours: 11/26/2025, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NXRT. NXRT was compared to 20 industry peers in the Residential REITs industry. NXRT has a bad profitability rating. Also its financial health evaluation is rather negative. NXRT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NXRT has reported negative net income.
NXRT had a positive operating cash flow in the past year.
Of the past 5 years NXRT 4 years were profitable.
In the past 5 years NXRT always reported a positive cash flow from operatings.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

NXRT's Return On Assets of -2.64% is on the low side compared to the rest of the industry. NXRT is outperformed by 90.00% of its industry peers.
With a Return On Equity value of -15.06%, NXRT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
NXRT has a worse Return On Invested Capital (1.26%) than 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NXRT is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROIC 1.26%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of NXRT has declined.
Looking at the Operating Margin, with a value of 11.35%, NXRT is doing worse than 70.00% of the companies in the same industry.
In the last couple of years the Operating Margin of NXRT has grown nicely.
NXRT's Gross Margin of 63.29% is amongst the best of the industry. NXRT outperforms 90.00% of its industry peers.
In the last couple of years the Gross Margin of NXRT has declined.
Industry RankSector Rank
OM 11.35%
PM (TTM) N/A
GM 63.29%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

NXRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NXRT has less shares outstanding than it did 1 year ago.
NXRT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NXRT has a worse debt to assets ratio.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.42, we must say that NXRT is in the distress zone and has some risk of bankruptcy.
NXRT's Altman-Z score of 0.42 is on the low side compared to the rest of the industry. NXRT is outperformed by 65.00% of its industry peers.
NXRT has a debt to FCF ratio of 33.86. This is a negative value and a sign of low solvency as NXRT would need 33.86 years to pay back of all of its debts.
NXRT has a Debt to FCF ratio (33.86) which is in line with its industry peers.
NXRT has a Debt/Equity ratio of 4.55. This is a high value indicating a heavy dependency on external financing.
NXRT has a Debt to Equity ratio of 4.55. This is amonst the worse of the industry: NXRT underperforms 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Altman-Z 0.42
ROIC/WACC0.16
WACC7.67%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.72 indicates that NXRT may have some problems paying its short term obligations.
NXRT has a better Current ratio (0.72) than 65.00% of its industry peers.
NXRT has a Quick Ratio of 0.72. This is a bad value and indicates that NXRT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NXRT (0.72) is better than 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

NXRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.25%.
Measured over the past years, NXRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -65.41% on average per year.
Looking at the last year, NXRT shows a decrease in Revenue. The Revenue has decreased by -4.46% in the last year.
NXRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.48% yearly.
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%

3.2 Future

Based on estimates for the next years, NXRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -287.31% on average per year.
Based on estimates for the next years, NXRT will show a small growth in Revenue. The Revenue will grow by 2.48% on average per year.
EPS Next Y-6407.02%
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%
EPS Next 5YN/A
Revenue Next Year-2.51%
Revenue Next 2Y0.18%
Revenue Next 3Y1.61%
Revenue Next 5Y2.48%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NXRT.
NXRT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NXRT is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.58
EV/EBITDA 18.06
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as NXRT's earnings are expected to decrease with -287.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.94%, NXRT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.26, NXRT pays a bit more dividend than its industry peers.
NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 6.94%

5.2 History

The dividend of NXRT is nicely growing with an annual growth rate of 10.88%!
NXRT has paid a dividend for at least 10 years, which is a reliable track record.
As NXRT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)10.88%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

NXRT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-109.03%
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

NEXPOINT RESIDENTIAL

NYSE:NXRT (11/26/2025, 8:04:00 PM)

After market: 31.77 0 (0%)

31.77

-0.23 (-0.72%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners75.78%
Inst Owner Change2.45%
Ins Owners13.32%
Ins Owner Change0%
Market Cap805.69M
Revenue(TTM)252.99M
Net Income(TTM)-48.65M
Analysts72.86
Price Target35.19 (10.76%)
Short Float %2.43%
Short Ratio3.21
Dividend
Industry RankSector Rank
Dividend Yield 6.94%
Yearly Dividend1.93
Dividend Growth(5Y)10.88%
DP-109.03%
Div Incr Years9
Div Non Decr Years9
Ex-Date12-15 2025-12-15 (0.53)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.4%
Min EPS beat(2)12.33%
Max EPS beat(2)18.46%
EPS beat(4)3
Avg EPS beat(4)-34.15%
Min EPS beat(4)-176.12%
Max EPS beat(4)18.46%
EPS beat(8)6
Avg EPS beat(8)63.98%
EPS beat(12)7
Avg EPS beat(12)18.82%
EPS beat(16)9
Avg EPS beat(16)53.78%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-2%
Max Revenue beat(4)-1.36%
Revenue beat(8)2
Avg Revenue beat(8)3.27%
Revenue beat(12)3
Avg Revenue beat(12)1.74%
Revenue beat(16)5
Avg Revenue beat(16)1.32%
PT rev (1m)-2.82%
PT rev (3m)-2.82%
EPS NQ rev (1m)-10%
EPS NQ rev (3m)-13.49%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)1.98%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.18
P/FCF 18.58
P/OCF 9.6
P/B 2.49
P/tB 2.49
EV/EBITDA 18.06
EPS(TTM)-1.89
EYN/A
EPS(NY)-1.25
Fwd EYN/A
FCF(TTM)1.71
FCFY5.38%
OCF(TTM)3.31
OCFY10.42%
SpS9.98
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROCE 1.59%
ROIC 1.26%
ROICexc 1.27%
ROICexgc 1.28%
OM 11.35%
PM (TTM) N/A
GM 63.29%
FCFM 17.14%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
ROICexc(3y)1.38%
ROICexc(5y)1.1%
ROICexgc(3y)1.43%
ROICexgc(5y)1.13%
ROCE(3y)1.73%
ROCE(5y)1.38%
ROICexgc growth 3Y22.72%
ROICexgc growth 5Y15.26%
ROICexc growth 3Y21.87%
ROICexc growth 5Y14.79%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Debt/EBITDA 11.72
Cap/Depr 42.01%
Cap/Sales 16.04%
Interest Coverage 0.32
Cash Conversion 66.98%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 0.42
F-Score4
WACC7.67%
ROIC/WACC0.16
Cap/Depr(3y)106.97%
Cap/Depr(5y)173.62%
Cap/Sales(3y)38.98%
Cap/Sales(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
EPS Next Y-6407.02%
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%
Revenue Next Year-2.51%
Revenue Next 2Y0.18%
Revenue Next 3Y1.61%
Revenue Next 5Y2.48%
EBIT growth 1Y-15.85%
EBIT growth 3Y19.26%
EBIT growth 5Y15.4%
EBIT Next Year18452.7%
EBIT Next 3Y497.35%
EBIT Next 5Y288.05%
FCF growth 1Y206.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.06%
OCF growth 3Y0.14%
OCF growth 5Y7.45%

NEXPOINT RESIDENTIAL / NXRT FAQ

Can you provide the ChartMill fundamental rating for NEXPOINT RESIDENTIAL?

ChartMill assigns a fundamental rating of 2 / 10 to NXRT.


What is the valuation status of NEXPOINT RESIDENTIAL (NXRT) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEXPOINT RESIDENTIAL (NXRT). This can be considered as Overvalued.


What is the profitability of NXRT stock?

NEXPOINT RESIDENTIAL (NXRT) has a profitability rating of 3 / 10.


How financially healthy is NEXPOINT RESIDENTIAL?

The financial health rating of NEXPOINT RESIDENTIAL (NXRT) is 2 / 10.